On January 8, 2024, AgeX Therapeutics, Inc.'s Board of Directors increased the size of the Board of Directors to four directors and appointed Steven Mintz as a director to fill the new vacancy on the Board. Mr. Mintz has been appointed to serve on the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee of the Board. Steven Mintz has been a self-employed financial consultant since 1998 serving both private individuals and companies, as well as public companies in a variety of industries including mining, oil and gas, real estate and investment strategies.

He is currently President of St. Germain Capital Corp. He is also a principal and CFO of the Minkids Group.

Mr. Mintz is currently a director of Portage Biotech, Inc. Mr. Mintz previously served as a director of IM Cannabis (formerly Navasota Resources). Mr. Mintz graduated from the University of Toronto in 1989 and obtained his C.A. designation in June of 1992.